Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 3177 (MIR3177, also known as hsa-mir-3177) is a short non-coding RNA molecule, part of the microRNA (miRNA) family, which are typically 20-24 nucleotides in length and regulate gene expression post-transcriptionally by affecting mRNA stability and translation in multicellular organisms[1]. MIR3177 is classified as a microRNA gene, and while the general function of miRNAs is to participate in gene silencing via incorporation into RNA-induced silencing complexes (RISC), no specific biological pathway, disease mechanism, or validated therapeutic targeting data exists for MIR3177[1]. Diseases such as Factor V deficiency and Vitelliform macular dystrophy are mentioned alongside MIR3177 in some gene annotation resources, but there is no evidence that MIR3177 directly underlies these phenotypes or acts as a direct therapeutic target[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 3177 (MIR3177).